Abstract

The Author addresses end-of-life issues so as to take into account the points of view of the subjects involved in these situation as provided for in art. 32 of the It. Const. This is done in order to satisfy the necessity of personalized therapies and the appropriateness of medical treatments. Starting from here, the Author analyses informed consent in the light of the social function that can be recognised to the medical profession and a distinction between the patient's refusal or initial dissent and the refusal to continue a treatment that has already been started. The Author goes on to underline the aporetic implications of transposing, without due adaptation, private autonomy (and representation) from the context of patrimonial rights to individual rights.